Benzoxaborole as a new chemotype for carbonic anhydrase inhibition(319 views visite) Alterio V, Cadoni R, Esposito D, Vullo D, Fiore AD, Monti SM, Caporale A, Ruvo M, Sechi M, Dumy P, Supuran CT, De Simone G, Winum JY
Keywords Parole chiave: Not available. Non disponibili.
Affiliations Affiliazioni: *** IBB - CNR ***
Istituto di Biostrutture e Bioimagini-CNR, Naples, Italy.
Institut des Biomolécules Max Mousseron (IBMM) UMR5247 CNRS, ENSCM, Université de Montpellier, Montpellier, France.
Laboratorio di Chimica Bioinorganica, Polo Scientifico, Università degli Studi di Firenze, Sesto Fiorentino, Florence, Italy.
Dipartimento di Chimica e Farmacia, Università degli Studi di Sassari, Sassari, Italy.
Neurofarba Department, Section of Pharmaceutical and Nutriceutical Sciences, Università degli Studi di Firenze, Sesto Fiorentino, Florence, Italy.
References Riferimenti: V. Alterio, A. Di Fiore, K. D'Ambrosio, C. T. Supuran and G. De Simone, Chem. Rev., 2012, 112,
McDonald, A. Oloumi, S. Chia, C. Ostlund, A. Ahmadi, A. Kyle, U. Auf dem Keller, S. Leung, D. Huntsman, B. Clarke, B. W. Sutherland, D. Waterhouse, M. Bally, C. Roskelley, C. M. Overall, A. Minchinton, F. Pacchiano, F. Carta, A. Scozzafava, N. Touisni, J. Y. Winum, C. T. Supuran and S. Dedhar, Cancer Res., 2011, 71, 3364.
Scozzafava, J. L. Montero and C. T. Supuran, Biorg. Med. Chem., 2009, 17, 3649.
Winum, R. A. Hall, F. A. Muhlschlegel, A. Scozzafava and C. T. Supuran, Bioorg. Med. Chem. Lett., 2009, 19, 2642.
Wang, H. Li, J. Shi, J. Wang, Z. Liu, S. Chen, S. Hu and Y. Zhu, Biorg. Med. Chem., 2016, 24, 2576.
Kauffman, Cancer Invest., 2004, 22, 304.
Daniels, J. Labutti, I. Parsons, D. Nix, E. Baronas, F. Hsieh, L. S. Gan and G. Miwa, Drug metabolism and disposition:
the biological fate of chemicals, 2005, 33, 771.
Plattner and S. Chanda, Environ. Mol. Mutagen., 2013, 54, 338.
Snyder, J. Org. Chem., 1964, 29, 3229.
M. Borys and A. Sporzynski, Chem. Rev., 2015, 115, 5224.
Zhang, T. Akama, A. Lau, H. Zhou, V. Hernandez, W. Mao, M. R. K. Alley, V. Sanders and J. J. Plattner, J. Med. Chem., 2006, 49, 4447.
Yaremchuk, M. Tukalo, T. Crepin, H. Zhou, Y. K. Zhang, V. Hernandez, T. Akama, S. J. Baker, J. J. Plattner, L. Shapiro, S. A. Martinis, S. J. Benkovic, S. Cusack and M. R. Alley, Science, 2007, 316, 1759.
K. Cyrański, A. Żubrowska and A. Sporzyński, J. Organomet. Chem., 2009, 694, 3533.
Snyder, J. Am. Chem. Soc., 1960, 82, 2172.
Virtucio, D. Sullivan, Y. Zhou, Y. K. Zhang, F. Rock, Y. Freund, L. Liu, W. Bu, A. Wu, X. Q. Fan and K. Jarnagin, J.
Pharmacol. Exp. Ther., 2013, 347, 615.
Jiangpeng, T. Aiping, X. Yongmei and W. Yuquan, Synthesis, 2013, 45, 2843.
Supuran, Nat. Rev. Drug Discov., 2011, 10, 767.
V. Alterio, S. M. Monti, J. Ombouma, P. Dumy, D. Vullo, C. T. Supuran, J. Y. Winum and G. De Simone, Chem. Commun., 2015, 51, 11519.
Skubak, A. A. Lebedev, N. S. Pannu, R. A. Steiner, R. A. Nicholls, M. D. Winn, F. Long and A. A. Vagin, Acta
Crystallogr. D Biol. Crystallogr., 2011, 67, 355.
Ballard, K. D. Cowtan, E. J. Dodson, P. Emsley, P. R. Evans, R. M. Keegan, E. B. Krissinel, A. G. Leslie, A. McCoy, S. J. McNicholas, G. N. Murshudov, N. S. Pannu, E. A. Potterton, H. R. Powell, R. J. Read, A. Vagin and K. S. Wilson, Acta Crystallogr. D Biol. Crystallogr., 2011, 67, 235.
Jones and A. Liljas, Proteins, 1988, 4, 274.
Plattner, B. Nare, S. A. Wring, D. Chen, Y. Freund, E. G. Gaukel, M. D. Orr, J. B. Perales, M. Jenks, R. A. Noe, J. M. Sligar, Y. K. Zhang, C. J. Bacchi, N. Yarlett and R. Don, Future Med. Chem., 2011, 3, 1259.
Wong, S. Farr-Jones, A. B. Shenvi and C. A. Kettner, Biochemistry, 1988, 27, 7689.
D. G. Hall and S. J. Benkovic, ACS Med. Chem. Lett., 2012, 3, 48.
Benzoxaborole as a new chemotype for carbonic anhydrase inhibition
In this paper we report the synthesis of a series of benzoxaborole derivatives, their inhibition properties against some carbonic anhydrases (CAs), recognized as important drug targets, and the characterization of the binding mode of these molecules to the CA active site. Our data provide the first experimental evidence that benzoxaboroles can be efficiently used as CA inhibitors.
Benzoxaborole as a new chemotype for carbonic anhydrase inhibition
226 Records (216 escludendo Abstract e Conferenze). Impact factor totale: 1021.339 (987.137 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 970.221 (934.828 escludendo Abstract e Conferenze).
Last modified by Ultima modifica di Giuseppina De Simone on in data Sunday 12 July 2020, 13:14:46 319 views visite. Last view on Ultima visita in data Thursday 15 April 2021, 6:26:11